In this issue:
- Gene therapy for haemophilia B using CB 2679d-GT
- Real-world TRA use in older patients with primary ITP
- Reduced calf muscle pump function increases VTE risk
- FXII: pathogenic role in organ failure and death with S. aureus
- PE risk after removing upperextremity CVC for DVT
- Thrombosis in paediatric patients with COVID-19/MIS
- DOACs for treating/preventing VTE in obese patients
- Postoperative LMWH bridging when arterial thromboembolism risk is high
- FVIII activity and bleeding risk during prophylaxis for severe haemophilia A
- Abelacimab for VTE prevention
Please login below to download this issue (PDF)